Novel penetration-promoting agent composition and application thereof to transdermal administration system

A technology of a transdermal drug delivery system and a penetration enhancer, applied in the pharmaceutical field, can solve problems such as loss of viscosity, cold flow, and limited dissolution of levonorgestrel

Active Publication Date: 2011-01-12
广东伊康纳斯生物医药科技股份有限公司 +1
View PDF17 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to solve the problem of dissolving levonorgestrel and estrogen, some dissolution-promoting and penetration-promoting systems use dimethyl sulfoxide (DMSO) to increase the dissolution of levonorgestrel and increase the penetration of levonorgestrel. The publication number is CN1399533 The Chinese patent disclosed a transdermal contraceptive drug delivery system. The skin penetration enhancer composition of this system uses dimethyl sulfoxide (DMSO). This system has a good transdermal rate for human skin, but due to the current The potential toxicity of dimethyl sulfoxide to the human body is still controversial. For safety reasons, the use of dimethyl sulfoxide (DMSO) should be avoided in penetration enhancer compositions.
There are also many fatty ester penetration enhancers that have been proven to have good penetration enhancement effects on levonorgestrel, for example, methyl laurate, polyethylene glycol monolaurate, poly Propylene glycol monolaurate (Polypropylene glycolmonolaurate), but these penetration enhancers, as plasticizers, have a serious damage to

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel penetration-promoting agent composition and application thereof to transdermal administration system
  • Novel penetration-promoting agent composition and application thereof to transdermal administration system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] Steroid hormones: levonorgestrel 0.05g, ethinyl estradiol 0.05g;

[0082] Viscosity regulator: PVP / VA copolymer (VA64) 0.1g;

[0083] Penetration enhancer 5g: propylene glycol 2.5g, diethylene glycol monoethyl ether 2.5g;

[0084] Adhesive polymer: GMS737 20g

[0085] The measured transdermal rate of levonorgestrel was 0.14 μg / cm 2 / h, ethinyl estradiol transdermal rate: 0.14μg / cm 2 / h.

Embodiment 2

[0087] Steroid hormones: levonorgestrel 0.2g, ethinyl estradiol 0.1g;

[0088] Viscosity modifier: PVP / VA copolymer (VA64) 1.5g;

[0089] Penetration enhancer 6g: propylene glycol 2g, diethylene glycol monoethyl ether 4g;

[0090] Viscous polymer: GMS737 30g;

[0091] The measured transdermal rate of levonorgestrel was 0.16 μg / cm 2 / h, ethinyl estradiol transdermal rate: 0.12μg / cm 2 / h.

Embodiment 3

[0093] Steroid hormones: levonorgestrel 0.3g, ethinyl estradiol 0.1g;

[0094] Viscosity modifier: PVP / VA copolymer (S-630) 0.3g;

[0095] Penetration enhancer 8g: propylene glycol 2g, isosorbide dimethyl ether 6g;

[0096] Adhesive polymer: GMS737 40g;

[0097] The measured transdermal rate of levonorgestrel was 0.20 μg / cm 2 / h, ethinyl estradiol transdermal rate: 0.12μg / cm 2 / h.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Skin penetration rateaaaaaaaaaa
Skin penetration rateaaaaaaaaaa
Skin penetration rateaaaaaaaaaa
Login to view more

Abstract

The invention provides a novel penetration-promoting agent composition and the application thereof to a transdermal administration system. The penetration-promoting agent provided by the invention contains an etheric compound and an alcohol compound and more preferably contains fatty acid having 6 to 18 carbon atoms or fatty alcohol having 6 to 18 carbon atoms. In the penetration-promoting agent of the invention, dimethylsulfoxide (DMSO) with controversial potential toxicity to a human body is not used; and an obtained product has the advantages of high transdermal rate, high adhesion, no potential toxic or side effect to the human body and safe and comfortable use. The transdermal administration system provided by the invention is applied by being stuck to the skin of a woman so as to fulfill the aims of effectively controlling birth and realizing conception control. The novel penetration-promoting agent composition can also be used for preventing and treating osteoporosis, climacteric metancholia of women and the like.

Description

technical field [0001] The invention relates to the field of pharmacy, in particular to a novel penetration enhancer composition and its application in a transdermal drug delivery system. Background technique [0002] A combination of synthetic estrogen and progestin, often used for contraception. If a combination of natural estrogen (17-beta estradiol) and progesterone (progesterone) is used in the form of an oral contraceptive pill, these two hormones undergo extensive primary metabolism in the liver requiring the use of very large doses. The resulting metabolites often cause undesired side effects. Therefore, synthetic progesterone and estrogen compositions are now mainly used as oral contraceptives to overcome these defects. Among them, one of the most representative combinations in oral contraceptives is the combination of levonorgestrel and ethinyl estradiol. [0003] Although the combination of synthetic progesterone and estrogen is very effective in suppressing ov...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/10A61K47/08A61K47/26A61K47/34A61K47/12A61K47/32A61K47/38A61K9/70A61K31/57A61K31/569A61K31/567A61K31/565A61P15/18A61P19/10A61P15/12
CPCA61K31/56A61K9/7023A61P5/00A61P15/12A61P15/18A61P19/10
Inventor 杨明京郑会义夏敏吴树明
Owner 广东伊康纳斯生物医药科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products